A detailed history of Verition Fund Management LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 43,561 shares of SMMT stock, worth $838,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,561
Previous 18,677 133.23%
Holding current value
$838,549
Previous $409,000 89.98%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$17.52 - $23.46 $435,967 - $583,778
24,884 Added 133.23%
43,561 $777,000
Q3 2024

Nov 14, 2024

BUY
$6.89 - $31.93 $128,684 - $596,356
18,677 New
18,677 $409,000
Q1 2023

May 15, 2023

BUY
$1.38 - $5.41 $160,110 - $627,679
116,022 New
116,022 $203,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.87B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.